This implies that the expression of TF may be upregulated by these inflammatory factors and it may be of clinical value to detect the levels of these factors in CTEPH patients to provide further information on their condition and prognosis. The gene discussed is TF; the disease is chronic thromboembolic pulmonary hypertension.